Top 15+ Cc-5013 hay nhất
-
1.Efficacy Of CC-5013 (Revlimid Or Lenalidomide) In Patients With ...
Patients with primary systemic amyloidosis will be treated with CC-5013 (lenalidomide; Revlimid) as a single agent for 3 months. If their disease worsens or ...
Xem chi tiết » -
2.A Study Of CC-5013 Plus Dexamethasone Versus ... - Clinical Trials
A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma. The safety and scientific validity of ...
Xem chi tiết » -
3.Definition Of CC-5013 - NCI Dictionary Of Cancer Terms
CC-5013. A drug that is similar to thalidomide and is used alone or with other drugs to treat adults with certain types of follicular lymphoma, marginal zone ...
Xem chi tiết » -
4.Immunomodulatory Drug CC-5013 Overcomes Drug Resistance And ...
Thalidomide (Thal) can overcome drug resistance in multiple myeloma (MM) but is associated with somnolence, constipation, and neuropathy.
Xem chi tiết » -
5.Orally Administered Lenalidomide (CC-5013) Is Anti-angiogenic In ...
The thalidomide analogue and immunomodulatory drug (IMiD) lenalidomide (CC-5013, REVLIMID) is emerging as a useful treatment for a number of cancers and has ...
Xem chi tiết » -
6.Lenalidomide (CC-5013) | ≥99%(HPLC) | E3 Ligase Ligand Chemical
Lenalidomide also known as CC-5013 is TNF-alpha inhibitor. Lenalidomide with purity >99% & solubility DMSO is available. Find all the information about ...
Xem chi tiết » -
7.EU Clinical Trials Register
20 Nov 2009 · Sponsor's Protocol Code Number: CC-5013-PC-002. National Competent Authority: UK - MHRA. Clinical Trial Type: EEA CTA.
Xem chi tiết » -
8.Phase III Intergroup Study Of Lenalidomide (CC-5013) Versus ...
20 Nov 2009 · Phase III Intergroup Study of Lenalidomide (CC-5013) Versus Placebo Maintenance Therapy Following Single Autologous Stem Cell Transplant for ...
Xem chi tiết » -
9.Lenalidomide (CC-5013) | Immunomodulator - MedChemExpress
Lenalidomide is an orally active immunomodulator. Lenalidomide (CC-5013) is a ligand of ubiquitin E3 ligase cereblon (CRBN), and it causes selective ...
Xem chi tiết » -
10.Lenalidomide: An Immunomodulatory Drug | Future Oncology
Lenalidomide (CC-5013; Revlimid®) represents one compound in a category of new medications known as immunomodulatory drugs. These compounds are thalidomide ...
Xem chi tiết » -
11.Multiple-dose Pharmacokinetics And Safety Of CC-5013 In 15 ...
22 Sept 2016 · 2056 Background: CC-5013 is a member of a novel class of pharmaceutical compounds, known as immunomodulatory drugs (IMiDs™), which modulate ...
Xem chi tiết » -
12.Phase I Study To Determine The Safety, Tolerability And ... - Nature
2 Mar 2004 · We assessed the safety, tolerability and efficacy of the immunomodulatory drug, CC-5013 (REVIMID™), in the treatment of patients with ...
Xem chi tiết » -
13.Clinical Trial On Multiple Myeloma: CC-5013, Lenalidomide - ICH GCP
Open-Label, Single-Arm Study of the Safety and Efficacy of CC-5013 Monotherapy for Subjects With Multiple Myeloma: A Companion Study for Studies THAL-MM-003 ...
Xem chi tiết » -
14.Preliminary Results Of A Phase II Study Of CC-5013 (Lenalidomide ...
16 Nov 2005 · Poster Sessions. Preliminary Results of a Phase II Study of CC-5013 (Lenalidomide, Revlimid®) in Patients with Cutaneous T-Cell Lymphoma. Author ...
Xem chi tiết » -
15.Lenalidomide (CC-5013) | CALIBRE SCIENTIFIC
Lenalidomide (CC-5013). Calibre Catalog Number: UBP-F5210-10. Category: Chemicals and Reagents. Market: Life Sciences. Brand: UBP Biotechnologies.
Xem chi tiết »